Skip to main content

Publications search

Found 37173 matches. Displaying 4691-4700
Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, Cedazo-Minguez A, Dubois B, Edvardsson D, Feldman H, Fratiglioni L, Frisoni GB, Gauthier S, Georges J, Graff C, Iqbal K, Jessen F, Johansson G, Jonsson L, Kivipelto M, Knapp M, Mangialasche F, Melis R, Nordberg A, Rikkert MO, Qiu CX, Sakmar TP, Scheltens P, Schneider LS, Sperling R, Tjernberg LO, Waldemar G, Wimo A, Zetterberg H
Show All Authors

Defeating Alzheimer's disease and other dementias: a priority for European science and society

LANCET NEUROLOGY 2016 APR; 15(5):455-532
Feng B, Hou DF, Ren HC, Wu PP
Show All Authors

Bose-Einstein condensation of bound pairs of relativistic fermions in a magnetic field

PHYSICAL REVIEW D 2016 APR 14; 93(8):? Article 085019
The Bose-Einstein condensation of bound pairs made of equally and oppositely charged fermions in a magnetic field is investigated using a relativistic model. The Gaussian fluctuations have been taken into account in order to study the spectrum of bound pairs in the strong coupling region. We found, in the weak coupling region, that the condensation temperature increases with an increasing magnetic field displaying the magnetic catalysis effect. In the strong coupling region, the inverse magnetic catalysis appears when the magnetic field is low and is replaced by the usual magnetic catalysis effect when magnetic field is sufficiently high, in contrast to the nonrelativistic case where the inverse magnetic catalysis prevails in the strong coupling region regardless of the strength of the magnetic field. The resulting response to the magnetic field is the consequence of the competition between the dimensional reduction by Landau orbitals in pairing dynamics and the anisotropy of the kinetic spectrum of the bound pairs. We thus conclude that dimensional reduction dominates in the weak domain and strong coupling one except in the small magnetic field region, where the enhanced fluctuations dominate.
Czarnowicki T, Malajian D, Khattri S, da Rosa JC, Dutt R, Finney R, Dhingra N, Peng XY, Xu H, Estrada YD, Zheng XZ, Gilleaudeau P, Sullivan-Whalen M, Suarez-Farinas M, Shemer A, Krueger JG, Guttman-Yassky E
Show All Authors

Petrolatum: Barrier repair and antimicrobial responses underlying this "inert" moisturizer

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 2016 APR; 137(4):1091-1102
Background: Petrolatum is a common moisturizer often used in the prevention of skin infections after ambulatory surgeries and as a maintenance therapy of atopic dermatitis (AD). However, the molecular responses induced by petrolatum in the skin have never been assessed. Objective: We sought to define the cutaneous molecular and structural effects induced by petrolatum. Methods: Thirty-six healthy subjects and 13 patients with moderate AD (mean SCORAD score, 39) were studied by using RT-PCR, gene arrays, immunohistochemistry, and immunofluorescence performed on control skin, petrolatum-occluded skin, and skin occluded with a Finn chamber only. Results: Significant upregulations of antimicrobial peptides (S100A8/fold change [FCH], 13.04; S100A9/FCH, 11.28; CCL20/FCH, 8.36; PI3 [elafin]/FCH, 15.40; lipocalin 2/FCH, 6.94, human beta-defensin 2 [DEFB4A]/FCH, 4.96; P < .001 for all) and innate immune genes (IL6, IL8, and IL1B; P < .01) were observed in petrolatum-occluded skin compared with expression in both control and occluded-only skin. Application of petrolatum also induced expression of key barrier differentiation markers (filaggrin and loricrin), increased stratum corneum thickness, and significantly reduced T-cell infiltrates in the setting of "normal-appearing" or nonlesional AD skin, which is known to harbor barrier and immune defects. Conclusions: Petrolatum robustly modulates antimicrobials and epidermal differentiation barrier measures. These data shed light on the beneficial molecular responses of petrolatum in barrier-defective states, such as AD and postoperative wound care.
Tabansky I, Messina MD, Bangeranye C, Goldstein J, Blitz-Shabbir KM, Machado S, Jeganathan V, Wright P, Najjar S, Cao YH, Sands W, Keskin DB, Stern JNH
Show All Authors

Advancing drug delivery systems for the treatment of multiple sclerosis (vol 63, pg 58, 2015)

IMMUNOLOGIC RESEARCH 2016 APR; 64(2):640-640
Miller CT, Freiwald WA, Leopold DA, Mitchell JF, Silva AC, Wang XQ
Show All Authors

Marmosets: A Neuroscientific Model of Human Social Behavior

NEURON 2016 APR 20; 90(2):219-233
The common marmoset (Callithrix jacchus) has garnered interest recently as a powerful model for the future of neuroscience research. Much of this excitement has centered on the species' reproductive biology and compatibility with gene editing techniques, which together have provided a path for transgenic marmosets to contribute to the study of disease as well as basic brain mechanisms. In step with technical advances is the need to establish experimental paradigms that optimally tap into the marmosets' behavioral and cognitive capacities. While conditioned task performance of a marmoset can compare unfavorably with rhesus monkey performance on conventional testing paradigms, marmosets' social behavior and cognition are more similar to that of humans. For example, marmosets are among only a handful of primates that, like humans, routinely pair bond and care cooperatively for their young. They are also notably pro-social and exhibit social cognitive abilities, such as imitation, that are rare outside of the Apes. In this Primer, we describe key facets of marmoset natural social behavior and demonstrate that emerging behavioral paradigms are well suited to isolate components of marmoset cognition that are highly relevant to humans. These approaches generally embrace natural behavior, which has been rare in conventional primate testing, and thus allow for a new consideration of neural mechanisms underlying primate social cognition and signaling. We anticipate that through parallel technical and paradigmatic advances, marmosets will become an essential model of human social behavior, including its dysfunction in neuropsychiatric disorders.
Hartnett J, Thom B, Kline N
Show All Authors

Caregiver Burden in End-Stage Ovarian Cancer

CLINICAL JOURNAL OF ONCOLOGY NURSING 2016 APR; 20(2):169-173
Background: Caregiver burden associated with caring for women with ovarian cancer has received limited focus. However, these patients often have complex needs, requiring a high level of care at home and imposing substantial burdens on caregivers. Objectives: This pilot study assessed the level of caregiver burden experienced by the primary caregivers of patients with end-stage ovarian cancer and identified variables associated with caregiver burden. Methods: Caregiver burden was assessed using the Caregiver Reaction Assessment. Fifty caregivers completed an anonymous and voluntary survey. Pearson correlations and independent samples t tests were used to analyze data. Findings: Most participants were Caucasian, married or living with a partner, and college graduates, with an annual household income of less than $90,000. Caregiver ages ranged from 29-81 years. Participants agreed most with the self-esteem scale, indicating they had pride in caring for their loved ones. Disrupted schedules and financial problems were the most burdensome factors in providing care. Because financial issues affected caregiver burden, nurses should facilitate interdisciplinary support. Future research is needed to determine the impact of nurse-led interventions to reduce caregiver burden.
Fuentes-Duculan J, Gulati N, Bonifacio KM, Kunjravia N, Zheng XZ, Suarez-Farinas M, Shemer A, Guttman-Yassky E, Krueger JG
Show All Authors

Biomarkers of alopecia areata disease activity and response to corticosteroid treatment

EXPERIMENTAL DERMATOLOGY 2016 APR; 25(4):282-286
Alopecia areata (AA) is a common inflammatory disease targeting the anagen-stage hair follicle. Different cytokines have been implicated in the disease profile, but their pathogenic role is not yet fully determined. We studied biopsies of pretreatment lesional and non-lesional (NL) scalp and post-treatment (intra-lesional steroid injection) lesional scalp of 6 patchy patients with AA using immunohistochemistry and gene expression analysis. Immunohistochemistry showed increases in CD3(+), CD8(+) T cells, CD11c(+) dendritic cells and CD1a(+) Langerhans cells within and around hair follicles of pretreatment lesional scalp, which decreased upon treatment. qRT-PCR showed in pretreatment lesional scalp (compared to NL) significant increases (P < 0.05) in expression of inflammatory markers (IL-2, IL-2RA, JAK3, IL-15), Th1 (CXCL10 and CXCL9), Th2 (IL-13, CCL17 and CCL18), IL-12/IL-23p40 and IL-32. Among these, we observed significant downregulation with treatment in IL-12/IL-23p40, CCL18 and IL-32. We also observed significant downregulation of several hair keratins in lesional scalp, with significant upregulation of KRT35, KRT75 and KRT86 in post-treatment lesional scalp. This study shows concurrent activation of Th1 and Th2 immune axes as well as IL-23 and IL-32 cytokine pathways in lesional AA scalp and defined a series of response biomarkers to corticosteroid injection. Clinical trials with selective antagonists coupled with cytokine-pathway biomarkers will be necessary to further dissect pathogenic immunity.
Percher A, Ramakrishnan S, Thinon E, Yuan XQ, Yount JS, Hang HC
Show All Authors

Mass-tag labeling reveals site-specific and endogenous levels of protein S-fatty acylation

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2016 APR 19; 113(16):4302-4307
Fatty acylation of cysteine residues provides spatial and temporal control of protein function in cells and regulates important biological pathways in eukaryotes. Although recent methods have improved the detection and proteomic analysis of cysteine fatty (S-fatty) acylated proteins, understanding how specific sites and quantitative levels of this posttranslational modification modulate cellular pathways are still challenging. To analyze the endogenous levels of protein S-fatty acylation in cells, we developed amass-tag labelingmethod based on hydroxylamine-sensitivity of thioesters and selective maleimide-modification of cysteines, termed acyl-PEG exchange (APE). We demonstrate that APE enables sensitive detection of protein S-acylation levels and is broadly applicable to different classes of S-palmitoylated membrane proteins. Using APE, we show that endogenous interferon-induced transmembrane protein 3 is S-fatty acylated on three cysteine residues and site-specific modification of highly conserved cysteines are crucial for the antiviral activity of this IFN-stimulated immune effector. APE therefore provides a general and sensitive method for analyzing the endogenous levels of protein S-fatty acylation and should facilitate quantitative studies of this regulated and dynamic lipid modification in biological systems.
Yildirim I, Degen J, Tanenhaus MK, Jaeger TF
Show All Authors

Talker-specificity and adaptation in quantifier interpretation

JOURNAL OF MEMORY AND LANGUAGE 2016 APR; 87(?):128-143
Linguistic meaning has long been recognized to be highly context-dependent. Quantifiers like many and some provide a particularly clear example of context-dependence. For example, the interpretation of quantifiers requires listeners to determine the relevant domain and scale. We focus on another type of context-dependence that quantifiers share with other lexical items: talker variability. Different talkers might use quantifiers with different interpretations in mind. We used a web-based crowdsourcing paradigm to study participants' expectations about the use of many and some based on recent exposure. We first established that the mapping of some and many onto quantities (candies in a bowl) is variable both within and between participants. We then examined whether and how listeners' expectations about quantifier use adapts with exposure to talkers who use quantifiers in different ways. The results demonstrate that listeners can adapt to talker-specific biases in both how often and with what intended meaning many and some are used. (C) 2015 Elsevier Inc. All rights reserved.
Balbontin R, Villagra N, de la Gandara MP, Mora G, Figueroa-Bossi N, Bossi L
Show All Authors

Expression of IroN, the salmochelin siderophore receptor, requires mRNA activation by RyhB small RNA homologues

MOLECULAR MICROBIOLOGY 2016 APR; 100(1):139-155
The iroN gene of Salmonella enterica and uropathogenic Escherichia coli encodes the outer membrane receptor of Fe3+-bound salmochelin, a siderophore tailored to evade capture by the host's immune system. The iroN gene is under negative control of the Fur repressor and transcribed under iron limiting conditions. We show here that transcriptional de-repression is not sufficient to allow iroN expression, as this also requires activation by either of two partially homologous small RNAs (sRNAs), RyhB1 and RyhB2. The two sRNAs target the same sequence segment approximately in the middle of the 94-nucleotide 5 untranslated region (UTR) of iroN mRNA. Several lines of evidence suggest that base pair interaction stimulates iroN mRNA translation. Activation does not result from the disruption of a secondary structure masking the ribosome binding site; rather it involves sequences at the 5 end of iroN 5 UTR. In vitro toeprint' assays revealed that this upstream site binds the 30S ribosomal subunit provided that RyhB1 is paired with the mRNA. Altogether, our data suggest that RyhB1, and to lesser extent RyhB2, activate iroN mRNA translation by promoting entry of the ribosome at an upstream standby' site. These findings add yet an additional nuance to the polychromatic landscape of sRNA-mediated regulation.